Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 65, Issue 23, pp. 10686-10691
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 26, 2005
- Revision received October 4, 2005
- Accepted October 12, 2005
- Published first December 1, 2005.
Copyright & Usage
©2005 American Association for Cancer Research.
Author Information
- Silvy da Rocha Dias1,
- Frank Friedlos2,
- Yvonne Light1,
- Caroline Springer2,
- Paul Workman3, and
- Richard Marais1
- 1The Institute of Cancer Research, Signal Transduction Team, Cancer Research UK Centre for Cell and Molecular Biology, London, United Kingdom; 2Gene and Oncogene Targeting Team and 3Signal Transduction and Molecular Pharmacology Team, Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom
- Requests for reprints:
Richard Marais, Signal Transduction Team, Cancer Research UK Centre for Cell and Molecular Biology, The Institute of Cancer Research, 237 Fulham Road, London, United Kingdom. Phone: 44-20-7153-5171; Fax: 44-20-7153-5171; E-mail: richard.marais{at}icr.ac.uk.
December 2005
Volume 65, Issue 23
Volume 65, Issue 23
Activated B-RAF Is an Hsp90 Client Protein That Is Targeted by the Anticancer Drug 17-Allylamino-17-Demethoxygeldanamycin
Jump to section
Advertisement